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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe identification of breast cancer cell subpopulations featuring trulymalignant stem cell qualities is a challenge due to the complexity of
the disease and lack of general markers. By combining extensive single-cell gene expression profiling with three functional strategies for
cancer stem cell enrichment including anchorage-independent culture, hypoxia, and analyses of low-proliferative, label-retaining cells
derived from mammospheres, we identified distinct stem cell clusters in breast cancer. Estrogen receptor (ER)a+ tumors featured a clear
hierarchical organization with switch-like and gradual transitions between different clusters, illustrating how breast cancer cells transfer
between discrete differentiation states in a sequential manner. ERa breast cancer showed less prominent clustering but shared a quies-
cent cancer stem cell pool with ERa+ cancer. The cellular organizationmodel was supported by single-cell data from primary tumors. The
findings allow us to understand the organization of breast cancers at the single-cell level, thereby permitting better identification and
targeting of cancer stem cells.INTRODUCTION
Breast cancer is one of the world’s leading causes of cancer-
related death among women, characterized by a high de-
gree of heterogeneity in terms of histological, molecular,
and clinical features, affecting disease progression and
treatment response (Bertos and Park, 2011). This has led
to the classification of breast cancer into several subtypes
including classical histological and immunohistochemical
definitions of breast cancer types as well as molecularly
defined subgroups (Perou et al., 2000; Sørlie et al., 2001).
The seminal studies by Perou et al. and Sørlie et al. identi-
fied luminal, HER2-enriched, basal, and normal-breast-
like intrinsic breast cancers. At the transcriptomic level,
this classification was shown to be mainly driven by estro-
gen receptor a (ERa), and ERa-related and proliferation-
related genes (Reis-Filho and Pusztai, 2011). ERa-positive
(ERa+) and -negative (ERa) breast cancers are well recog-
nized asmolecularly and clinically distinct diseases. Several
hypotheses have been proposed to explain intertumoral
heterogeneity; including different genetic and epigenetic
aberrations as well as distinct subtype-specific tumor cells
of origin (Polyak, 2011).
Functional and phenotypic diversity has also been
described at the single-cell level within individual tumors.
Cells of various cancer types have been shown to differ
greatly in their tumorigenic, angiogenic, invasive, andmet-
astatic potential (Polyak, 2011). To account for intratu-
moral heterogeneity the cancer stem cell (CSC) model
suggests that tumors are driven by a cellular subpopulationStem Cewith stem cell properties, giving rise to hierarchically struc-
tured tumors. Attributes of CSCs comprise self-renewal,
tumorigenicity, multilineage differentiation, and increased
resistance to radiotherapy- and chemotherapy-induced cell
death (Badve and Nakshatri, 2012), making CSCs critical
targets in cancer therapy.
CSCs of breast tumors are commonly enriched by combi-
nations of several cell-surface antigens, such as CD44/
CD24/EPCAM (Al-Hajj et al., 2003), or by high ALDH (alde-
hyde dehydrogenase) activity (Ginestier et al., 2007). How-
ever, existing markers lack specificity, also reflective of a
substantial proportion of non-CSCs. Furthermore, the
applicability of existing markers is often limited to specific
breast cancer subtypes (Nakshatri et al., 2009) in addition
to interindividual intrinsic differences (Visvader and Lin-
deman, 2012). Previous studies have investigated the CSC
content in different breast cancer subtypes (Harrison
et al., 2013; Kim et al., 2012; Ricardo et al., 2011); however,
thus far it is not exactly known whether distinct subtypes
harbor the same or dissimilar CSCs. The large multitude
of assays currently employed indicates either a lack of uni-
versal markers or reflects the heterogenic and dynamic na-
ture of CSCs. The exact characterization of putative CSC
pools is a pivotal requirement for clinical identification,
monitoring, and targeting of these cells.
To elucidate the heterogeneity of the CSC pool and to
study the CSC compartment in ERa+ and ERa breast can-
cer subtypes, we set up a single-cell quantitative real-time
PCR (qPCR) approach, profiling the expression of well-es-
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stemness, epithelial-to-mesenchymal transition (EMT),
and cell-cycle regulation. Three functional assays for CSC
enrichment were applied: (1) growth in anchorage-inde-
pendent culture; (2) growth in hypoxia; and (3) cell selec-
tion based on label retention in mammosphere culture.
All methods have previously been shown to enrich for cells
that exhibit increased cancer-initiating potential in mouse
model systems (Harrison et al., 2010, 2013; Ponti et al.,
2005; Richichi et al., 2013). By extensive single-cell ana-
lyses of breast cancer cells, we now define hierarchically
organized CSC pools and modes of cell state transitions.RESULTS
To study CSC heterogeneity and cellular composition in
breast cancer, we applied three established techniques to
modulate the CSC pool; growth in anchorage-independent
culture (Harrison et al., 2010), hypoxia (Harrison et al.,
2013), and a combination of the lipophilic PKH26 dye
and the mammosphere assay to select for lowly prolifera-
tive, mammosphere-initiating cells (Ponti et al., 2005; Ri-
chichi et al., 2013) (Figures 1A–1C). All CSC enrichment
methods have previously been demonstrated to enrich
for cells displaying various CSC features, such as increased
in vivo tumor-initiating capacity. Although in vivo data are
not reported in this study, for simplicity we refer to en-
riched cell fractions as CSCs. The expression of keymarkers
associated with differentiation (CDH1, CD24, EPCAM,
ESR1, PGR), breast cancer stemness (CD44, ITGA6, DNER,
ALDH1A3, ABCG2), pluripotency (POU5F1, NANOG,
SOX2), EMT/metastasis (SNAI1, SNAI2, FOSL1, VIM,
CDH2, ID1), and proliferation (CCNA2, MKI67, ERBB2)
was quantitatively assessed at the single-cell level (Figures
1D and 1E). Detailed gene and qPCR assay information is
provided in Table S1.Distinct Subpopulations with CSC and Differentiated
Phenotypes Define ERa+ Cell Lines
In the first approach to study CSC and progenitor pools, we
detailed anchorage-independent cultures, in which most
differentiated cells undergo anoikis whereas anoikis-resis-
tant (AR) cells with CSC properties will survive (DontuFigure 1. Workflow of CSC Enrichment Methods and Single-Cell G
(A–C) Breast cancer cell lines were cultured as regular monolayers,
techniques: (A) Growth in anchorage-independent culture (ERa+ and E
dividing, PKH26Bright cells cultured as mammospheres (MCF7 cells).
(D) Single-cell gene expression profiling. Individual cells were collect
on dry ice. Single-cell RNA was reverse transcribed, followed by targete
data were analyzed using various uni- and multivariate statistical too
(E) Analyzed genes grouped by known expression patterns based on
Supplemental Information.
Stem Ceet al., 2003; Harrison et al., 2010). Regular monolayer
(ML) and AR cultures were grown in parallel (Figure 1A)
and subsequently profiled at the single-cell level.
Principal-component analysis (PCA) of 157 individual
MCF7 cells (ML: n = 80; AR: n = 77) showed three distinct
cell clusters termed ERa+ I–III (Figure 2A). ERa+ I cells dis-
played high expression of the pluripotency-associated
genes NANOG and POU5F1, low transcript levels of differ-
entiation- and proliferation-related genes, and low overall
transcript levels, indicating that these cells may reside in
a quiescent state (Figures 2B, 2C, and S1A–S1E). ERa+ II
cells exhibited high expression of breast CSC-associated
genes (CD44, ALDH1A3, and ABCG2) and proliferation-
related genes (CCNA2, MKI67, and ERBB2) (Figures 2B,
2C, and S1A–S1E). ERa+ III cells were characterized by
high expression of differentiation-associated genes and
proliferation markers (Figures 2B, 2C, and S1A–S1E). AR
cells were enriched in clusters ERa+ I and II, while cluster
ERa+ III mainly included ML cells (Figure 2C). Hence, the
ERa+ I cluster corresponded to cells with CSC characteris-
tics, while clusters ERa+ II and ERa+ III comprised cells
that exhibited properties of progenitor and more differen-
tiated cells, respectively.
Similarly, PCA of 158 T47D cells (ML: n = 78; AR: n = 80)
identified two discrete clusters, designated ERa+ I and III, in
accordance with the definition used for MCF7 cells (Fig-
ure 2E). ERa+ I cells were distinguished by high expression
of SOX2, POU5F1, andNANOG and low overall RNA expres-
sion levels (Figures 2F, 2G, and S1F–S1J). ERa+ III cells
exhibited high transcript levels of differentiation- and pro-
liferation-associated genes (Figures 2F, 2G, and S1F–S1J).
Cluster ERa+ I primarily included AR cells, whereas cluster
ERa+ III mainly consisted of ML cells (Figure 2G). MCF7
and T47D cells defining clusters ERa+ I and III showed
similar gene expression characteristics.
To identify genes and processes involved in the applied
CSC enrichment method, we compared differentially ex-
pressed genes between ML and AR cells. In AR cells,
CDH1, CD24, EPCAM, ESR1, PGR, and ID1were downregu-
lated and FOSL1 upregulated in both cell types, while
CCNA2 was only downregulated in MCF7 cells (Figures
2D and 2H). This common regulation of MCF7 and T47D
cells suggests similar enrichment mechanisms. To furtherene Expression Profiling
and cancer stem-like cells were enriched using three established
Ra cell lines); (B) hypoxia (1% O2 for 48 hr) (MCF7 cells); (C) non-
ed by either FACS or microaspiration, lysed, and immediately frozen
d cDNA pre-amplification and quantitative real-time PCR. Single-cell
ls.
pre-existing literature. Full-length references are provided in the
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pursue this notion, we performed pairwise gene correlation
analysis at the single-cell level to identify mutual regu-
latory elements (Stahlberg and Bengtsson, 2010). Interest-
ingly, there were a larger number of correlations in AR cells
compared with ML cells, accompanied by an increase of
common correlations in MCF7 and T47D AR cells (Table
S4). Furthermore, the observed correlations in AR cells
linked differentiation-associated genes with proliferation
markers.
Proliferative Phenotypes Define ERa Breast Cancer
Cell Lines
Two ERa cell lines, CAL120 and MDA-MB-231
(MDA231), were next analyzed using the same experi-
mental setup as for ERa+ cells. PCA of 140 single
CAL120 cells (ML: n = 75; AR: n = 65) is illustrated in Fig-
ure 3A. Cells grouped into two clusters termed ERa I and
III in accordance with the nomenclature applied for ERa+
cell lines. ERa I cells displayed low overall RNA expres-
sion levels, whereas ERa III cells were characterized by
high expression of 14 genes, belonging to all defined
gene groups (Figures 3B, 3C, and S2A–S2E). Cluster
ERa III harbored the majority of all analyzed cells, while
AR cells were slightly enriched in cluster ERa I, suggest-
ing that cluster ERa I cells represent a slow-dividing/
quiescent cell pool characteristic of CSCs (Fillmore and
Kuperwasser, 2008).
Likewise, PCA of 159 individual MDA231 cells (ML: n =
84; AR: n = 75) revealed the presence of two cell clusters
ERa II and III. ALDH1A3, ABCG2, and SNAI1 were
marginally, but not significantly, upregulated in ERa II
cells (Figures S2F–S2J). ERa III cells exhibited elevated
expression of FOSL1, VIM, CCNA2, and MKI67 (Figures
3F, 3G, and S2F–S2J). AR cells were enriched in cluster
ERa II, whereas ML cells were enriched in cluster
ERa III (Figure 3G).
As for ERa+ cell lines, most affected genes were downre-
gulated in ERa cell lines when comparing AR cells
with ML cells (Figures 3D and 3H). Different genes wereFigure 2. Single-Cell Gene Expression Analysis of ERa+ Breast Ca
Single-cell gene expression profiling of ERa+ MCF7 and T47D cells gr
tant, AR) cultures.
(A and E) PCA scores of individual MCF7 and T47D cells. Identified ER
plot each cell is represented by a dot. The position of a cell is define
(B and F) PCA gene loadings, illustrating the contribution to the PCA
(C and G) Mean expression levels of the classified ERa+ I–III groups. T
at the bottom of the table. Statistical significance of groups was det
(D and H) Differentially expressed genes between ML and AR cells. Mea
and percentage of cells expressing a given gene are represented as bars
to identify significantly regulated genes, and p values were Bonferron
***p% 0.001. Number of analyzed cells: MCF7, ML: n = 80; AR: n =
See also Figures S1 and S3; Tables S2 and S4.
Stem Cedownregulated in CAL120 (CD44, CDH2, and MK167)
and MDA231 (ITGA6, SNAI2, FOSL1, and VIM), and only
CCNA2 and ID1 were downregulated in both ERa cell
lines. ABCG2 was the only upregulated gene in MDA231
AR cells (Figure 3H). In contrast to ERa+ AR cells, single-
cell gene correlation analysis revealed no increase in the
number of correlations comparing AR with ML cells (Fig-
ures S3E–S3H). Furthermore, the observed correlations
differed between the two cell types.
A Common CSC Subpopulation Can Be Identified in
ERa+ and ERa Cells
In an attempt to detect common subpopulations in breast
cancer cells, all single-cell data were normalized, pooled,
and subjected to combined analyses. In support for
similar behaviors between ERa+ and ERa cell lines,
PCA of all MCF7, T47D, CAL120, and MDA231 cells re-
vealed the presence of distinct subpopulations based on
their specific gene expression profiles (Figures 4A
and 4B). ERa+ cell lines defined three discrete clusters
(ERa+ I–III), whereas ERa cell lines congregated into
three partly separate clusters (ERa I–III), where clusters
ERa+ I and ERa I represented a common quiescent
CSC pool. The ERa+/ERa I cluster included cells of all
cell lines. Figure 4C shows in detail that ERa+ and ERa
CSCs cannot be separated from each other based on their
gene expression profiles. Cluster ERa+ II mainly contained
MCF7 AR cells, whereas cluster ERa+ III encompassed the
majority of all differentiated ERa+ ML cells. Clusters ERa
II–III harbored essentially all MDA231 cells as well as most
of the CAL120 cells (Figure S3B). The clusters defined
lowly (ERa II) or highly (ERa III) proliferative groups
of cells as indicated in Figure 4A. The defined clusters
were validated using an alternative hierarchical clustering
method (Figure S3A).
Figure 4D schematically illustrates the hierarchical organi-
zation between the identified subpopulations. Two distinct
modes of differentiation were identified in the ERa+ cell
lines. MCF7 cells differentiated via a progenitor-like statencer Cells Reveals Two Modes of Differentiation
own in monolayer (ML) and anchorage-independent (anoikis-resis-
a+ I–III groups are indicated by different colors. In the PCA scores
d by its gene expression profile.
scores in (A) and (E).
he percentages of ML and AR cells per identified group are indicated
ermined by Fisher’s exact test, ***p% 0.001.
n expression ± SEM are shown as dots (scale indicated at left y axis)
(scale indicated at right y axis). The Mann-Whitney U test was used
i adjusted to correct for multiple testing. *p% 0.05, **p% 0.01,
77; T47D, ML: n = 78; AR: n = 80.
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(ERa+ II), before they acquired a fully differentiated pheno-
type (ERa+ III), while T47D cells differentiatedwithout pass-
ing this progenitor-like state. ERa cell lines, on the other
hand, seemed to differentiate by increasing proliferative ca-
pacity from a common quiescent CSC-like pool shared with
ERa+ cells.
To validate our findings in a clinical context, we next
analyzed single cells from two primary breast cancer sam-
ples, one ERa+ (n = 81) and one ERa (n = 90) ductal can-
cer, collected directly after surgery without any pre-culture
period. Overall, cells from the primary tumors displayed
lower mean expression of most genes (Table S6) compared
with the cell lines (Tables S2 and S3). When analyzing the
two tumors together (Figures 4E and 4F), cells clustered
based on their origin (ERa+ or ERa) but with an overlap
of some cells sharing a similar gene expression profile.
This common cell pool was characterized by the expression
of pluripotency markers, while the other cells expressed
markers related tomore differentiated cell states. The num-
ber of cells with a common undifferentiated gene ex-
pression profile was rather high, potentially including
both common progenitor cells and CSCs. Figure 4G sum-
marizes the differentiation route in primary tumor cells,
which was in line with the cell hierarchy delineated for
the cell lines based on manipulation of the CSC fraction
(Figure 4D).
Hypoxia Enriches Two Distinct Populations with CSC
Characteristics in ERa+ MCF7 Cells
As an alternative CSC enrichment for ERa+ breast cancer,
we next used hypoxic growth conditions (Harrison et al.,
2013).MCF7 cells were cultured in hypoxia (1%O2) or nor-
moxia (21% O2) and collected after 48 hr for single-cell
gene expression profiling (Figure 1B). Hypoxic culture
was confirmed by 8.7-fold upregulation of carbonic anhy-
drase IX (CA9), a hypoxia-inducible factor 1a target gene
(Wykoff et al., 2000) (Figure 5A). Normoxic (n = 84) and
hypoxic (n = 84) cells formed no distinct clusters using
PCA (Figures 5B and 5C). Therefore, we applied KohonenFigure 3. Single-Cell Gene Expression Analysis of ERa Breast C
liferative Capacity
Single-cell gene expression profiling of ERa CAL120 and MDA231 c
resistant, AR) cultures.
(A and E) PCA scores of individual CAL120 and MDA231 cells. Identifi
scores plot each cell is represented by a dot. The position of a cell is
(B and F) PCA gene loadings, illustrating the contribution to the PCA
(C and G) Mean expression levels of the PCA-identified ERa I–III g
indicated at the bottom of the table. Statistical significance of group
(D and H) Differentially expressed genes between ML and AR cells. Mea
and percentage of cells expressing a given gene are represented as bars
to identify significantly regulated genes, and p values were Bonferron
***p% 0.001. Number of analyzed cells: CAL120, ML: n = 75; AR: n
See also Figures S2 and S3; Tables S3 and S4.
Stem Ceself-organizing maps (SOMs) (Stahlberg et al., 2011) to
define four relevant clusters (Hx I–IV) (Figure 5B). Hypoxic
cells were enriched in the Hx I and Hx II groups, whereas
normoxic cells dominated the Hx III andHx IV groups (Fig-
ures 5B and 5D). Hx I cells were characterized by elevated
expression of NANOG, SNAI1, SNAI2, and FOSL1, and low
levels of ESR1, PGR, and ID1. Hx II cells exhibited highest
expression of ABCG2, ALDH1A3, and CD44, and high
expression of proliferation markers Hx III and IV cells
were characterized by high levels of differentiationmarkers
and low expression of breast CSC-associated genes. Hx III
cells were mainly highly proliferative, whereas Hx IV cells
were lowly proliferative (Figures 5D and S4A–S4E). Impor-
tantly, the Hx I and II populations were also present in nor-
moxic culture condition although in lower proportions,
suggesting a shift in the cellular equilibrium toward a
more undifferentiated phenotype in hypoxia. When
comparing differentially expressed genes in normoxic
and hypoxic cells, we observed that EPCAM, ESR1, and
ID1 were downregulated in hypoxia whereas ABCG2 was
upregulated (Figure 5E), further supporting the notion
that ERa+ cells acquire an immature phenotype in hypoxic
culture.
For an extensive analysis of molecular networks relevant
to hypoxia inMCF7 cells, we extended the existing 21-gene
panel to 95 genes, including lineage-specific markers, cell-
cycle regulators, andmembers of the Notch pathway (Table
S1), which plays a role in the hypoxia-induced increase of
CSCs in ERa+ breast cancers (Harrison et al., 2013). PCA
of the 80 successfully pre-amplified genes showed cell
clusters similar to those portrayed in Figure 5B (Figures
S4F–S4G). Descriptive statistics for all 80 analyzed genes
are presented in Table S5.
Label-Retaining Mammosphere-Derived MCF7 Cells
Display Three Distinct Subpopulations with CSC-like
Phenotypes
Since asymmetric stem cell division may leave one long-
term lowly proliferative stem cell for later reactivation,ancer Cells Reveals Subpopulations of Cells with Variable Pro-
ells grown in monolayer (ML) or anchorage-independent (anoikis-
ed ERa I–III groups are indicated in different colors. In the PCA
defined by its gene expression profile.
scores in (A) and (E).
roups. The percentages of ML and AR cells per identified group are
s was determined by Fisher’s exact test, *p% 0.05.
n expression ± SEM are shown as dots (scale indicated at left y axis)
(scale indicated at right y axis). The Mann-Whitney U test was used
i adjusted to correct for multiple testing. *p% 0.05, **p% 0.01,
= 65; MDA231, ML: n = 84; AR, n = 75.
ll Reports j Vol. 6 j 121–136 j January 12, 2016 j ª2016 The Authors 127
(legend on next page)
128 Stem Cell Reports j Vol. 6 j 121–136 j January 12, 2016 j ª2016 The Authors
and our data (Figures 1, 2, 3, 4, and 5) show that a subpop-
ulation of cells with CSC characteristics are lowly prolifer-
ative, the next strategy to enrich for CSCs was to collect
individual mammosphere-initiating cells that had under-
gone few cell divisions. Mammosphere-initiating cells
were traced with the lipophilic PKH26 dye that diminishes
with each cell division (Pece et al., 2010) (Figure 1C). The
staining procedure did not significantly affect sphere
formation (Figure S5A) or size (data not shown) of MCF7
cells. Mammospheres were categorized into two differ-
ent PKH26-staining types: spheres containing a single
PKH26Bright cell (Figure S5B) and spheres exhibiting a
diffuse staining pattern (Figure S5C). When assessing the
number of distinct sphere types inMCF7 cells, we observed
that 40% of all MCF7 spheres (n = 141) contained one
PKH26Bright cell only, whereas 60% (n = 211) of the spheres
exhibited a diffuse staining pattern or multiple PKH26Bright
foci (Figure S5F). Besides the presence of PKH26Bright cells
in spheres, we regularly observed viable single PKH26Bright
cells in our cultures not forming any spheres (Figures S5D
and S5E). These cells could presumably have CSC features
but resided in a more permanent quiescent cell state. For
clarity, PKH26Bright single cells were eliminated frommam-
mosphere cultures by slow centrifugation.
To verify that PKH26Bright cells were located within a
mammosphere, we employed confocal microscopy and
imaged z stacks of PKH26-stained spheres (Figure 6A).
PKH26Bright, PKH26Intermediate, and PKH26Negative MCF7
cellular fractions were collected by fluorescence-activated
cell sorting (FACS), and bulk transcript levels of key genes
involved in differentiation, EMT, stemness, and prolifera-
tion demonstrated that PKH26Bright cells exhibited features
of lowly proliferative CSCs (Figure S5G) in comparison
with PKH26Intermediate and PKH26Negative cells. We then
collected PKH26Bright single cells using FACS (n = 90) or
manually picked single cells using a micromanipulator as
an alternative cell collection method (n = 14) (Figure 6B).
PCA of PKH26Bright cells revealed three distinct clustersFigure 4. ERa+ and ERa Cells Define a Common Quiescent Cell
Single-cell gene expression analysis of all 615 ERa+ and ERa breas
(A) PCA scores of individual MCF7, T47D (ERa+) as well as CAL120
anchorage-independent growth conditions (anoikis-resistant, AR). Ea
in the figure. Identified groups are indicated in different colors.
(B) PCA gene loadings, illustrating the contribution to the PCA score
(C) Cell-to-cell correlation heatmap of the ERa+/ERa I group using
black arrow heads.
(D) Hypothesized cellular organization of ERa+ and ERa cell lines. Th
indicated as bidirectional process, black arrows denote differentiatio
(E) PCA scores of individual cells generated from one ERa+ and one E
(F) PCA gene loadings, illustrating the contribution to the PCA score
(G) Hypothesized cellular organization of ERa+ and ERa primary tum
state conversions are indicated by arrows (red and blue, differentiati
Stem Ce(PKH I–III) (Figure 6C), featuring different gene expression
characteristics (Figure 6D). Of note, the manually picked
cells were present in all three groups, confirming unbiased
cell collection (Figure 6C). Most cells (82%) were present in
the PKH I and II clusters. PKH I cells displayed low expres-
sion of all analyzed genes, suggesting a quiescent cell state.
PKH II cells exhibited elevated expression of pluripotency-
associated genes as well as high expression ofCD44 and the
cell-cycle inhibitor CDKNA1 (p21). PKH III cells featured
high expression of proliferation and differentiation-associ-
ated genes, suggestive of a proliferative progenitor pool
(Figures 6E and S6).
ERa+MCF7Cells CompriseDistinct Cellular States and
Are Organized in a Hierarchical Manner
Combined PCA and SOMs of all MCF7 single-cell data
derived from the three CSC enrichment techniques,
including corresponding monolayer populations, allowed
us to relate and hierarchically organize identified pheno-
typic states. Individual cells could be divided into four
stable clusters (MCF7 I–IV) using SOMs (Figure 7A), each
presenting a unique gene expression signature (Figures 7B
and S7). Cells from the three enrichment techniques were
present in all defined clusters, although in varying propor-
tions (Figure 7C). Cluster MCF7 I was dominated by AR
cells and displayed high expression of EMT-related, plurip-
otency-related, and certain breast CSC-related genes (Fig-
ures S7A–S7E). Cluster MCF7 II primarily contained
PKH26Bright cells and was characterized by high expression
ofCD44 (Figure S7). ClusterMCF7 III was enriched for hyp-
oxic cells and to a lesser extent for PKH26Bright cells, with
high expression of most differentiation markers ABCG2
and ERBB2 (Figure S7). Most ML cells were present in clus-
ter MCF7 IV characterized by high expression of prolifera-
tion-associated genes, PGR, ALDH1A3, and ID1 (Figure S7).
The PCA in Figure 7A is similar to that in Figure 2A,
since the latter is a subset of all cells analyzed in Fig-
ure 7A. The groups relate to each other in the followingPool Featuring CSC-like Characteristics
t cancer cells.
and MDA231 (ERa) cells, cultured as monolayers (ML) and in
ch cell is represented by a symbol, specific for the cell line as shown
s in (A).
the Spearman correlation coefficient. ERa cells are indicated by
e model mimics the PCA score plot in (A). Cell state conversions are
n, and gray arrows indicate putative de-differentiation.
Ra primary tumor, respectively.
s in (D).
ors. The model mimics the PCA score plot in (E). Directions of cell
on; gray, de-differentiation).
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Figure 5. Hypoxia Enriches Two Distinct Populations with CSC Characteristics in ERa+ MCF7 Cells
Single-cell gene expression profiling of ERa+ MCF7 cells grown in normoxic (21% O2) and hypoxic (1% O2) culture for 48 hr.
(A) Fold change of carbonic anhydrase 9 (CA9) mRNA expression between normoxic and hypoxic MCF7 cells. Mean expression ± SD (n = 3) is
shown. Statistical significance was determined with Student’s t test, **p% 0.01.
(B) PCA scores of individual normoxic and hypoxic MCF7 cells. Cells have been divided into four stable groups based on Kohonen
self-organizing map (SOM) analysis, displayed as Hx I–IV. Normoxic and hypoxic cells are represented by dots and squares,
respectively.
(C) PCA gene loadings, signifying the contribution to the PCA scores in (B).
(D) Mean expression of PCA-identified Hx I–IV groups. The percentages of normoxic and hypoxic cells per SOM group are indicated at the
bottom of the table. Statistical significance of the identified groups was computed using the chi-square test, ***p% 0.001.
(legend continued on next page)
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Figure 6. Single-Cell Gene Expression Analysis of Label-Retaining Mammosphere-Initiating ERa+ MCF7 Cells Reveals Three
Distinct Subpopulations with CSC-like Features
Single-cell gene expression profiling of PKH26 label-retaining ERa+ MCF7 cells isolated from mammosphere cultures.
(A) Maximum-intensity projection of a confocal micrograph of a mammosphere containing a single PKH26Bright cell (white arrow).
(B) Micrograph of a PKH26Bright MCF7 single cell derived from dissociated mammospheres and collected by microaspiration.
(C) PCA scores of PKH26Bright MCF7 cells, collected by FACS (n = 90) and microaspiration (n = 14). Identified PKH I–III groups are indicated
by different colors. Each cell is represented by a dot.
(D) PCA gene loadings showing the contribution to the PCA scores in (C).
(E) Mean expression levels of the PCA-identified PKH I–III groups. The percentages of cells per SOM group are indicated at the bottom of
the table.
See also Figures S5 and S6.manner: MCF I corresponds to ERa+ I, MCF II–III corre-
sponds to ERa+ II, and MCF III corresponds to ERa+ III.
Based on the observed gradual gene regulation between
the identified clusters, we propose a hierarchical organiza-
tion of MCF7 cells (Figure 7D). In this scenario the
MCF7 I group featuring characteristics of quiescent CSCs
represents the apex of the hierarchy, and differentiation(E) Differentially expressed genes between normoxic and hypoxic cel
y axis) and percentage of cells expressing a given gene are represente
was used to identify significantly regulated genes, and p values were Bo
0.01, ***p% 0.001. Normoxic cells: n = 84; hypoxic cells: n = 84.
See also Figure S4 and Table S5.
Stem Cetakes place over different cellular states (MCF7 II and
MCF7 III) to the most differentiated cells in group MCF7
IV. First, epithelial genes become activated at the same
time as genes related to EMT, and breast CSCs become inac-
tivated. Then, in a second step, genes related to prolifera-
tion are upregulated at the same time as pluripotency genes
are downregulated.ls. Mean expression ± SEM is shown as dots (scale indicated at left
d as bars (scale indicated at right y axis). The Mann-Whitney U test
nferroni adjusted to correct for multiple testing. *p% 0.05, **p%
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Figure 7. ERa+ MCF7 Cells Feature Distinct Differentiation States Organized in a Hierarchical Manner
(A) PCA scores displaying ERa+ MCF7 cells. For a comprehensive analysis of cell types present, enriched anoikis-resistant (AR), hypoxic and
PKH26Bright cells, as well as corresponding monolayer (ML) populations were subjected to PCA. Cells were classified into four groups, MCF7
I–IV, using SOMs. Data were autoscaled by cell to compensate for absolute differences in expression levels.
(B) PCA gene loadings showing the contribution to the PCA scores in (A).
(C) Percentage of cells per identified MCF7 I–IV group. Statistical significance of the identified groups was verified by using the chi-square
test, ***p% 0.001.
(D) Proposed model displaying distinct identified cell states and hierarchical organization of MCF7 cells. The trend of gene expression of
epithelial/differentiation, breast cancer stem cell (BCSC), pluripotency, EMT/metastasis, and proliferation-associated genes are indicated
outside the box that mimics the PCA score plot in (A). Based on gradual gene regulation, differentiation and putative de-differentiation
likely take place sequentially via several progenitor states along the hierarchy as further highlighted by the gray crossed circle, indicating
a non-likely differentiation route.DISCUSSION
The CSC model suggests that tumors are driven by a small
subset of cells with self-renewing and differentiation capac-132 Stem Cell Reports j Vol. 6 j 121–136 j January 12, 2016 j ª2016 The Autity, giving rise to phenotypically diverse, hierarchically
organized tumors. CSCs display activated signaling path-
ways associated with normal stem cells and increased tu-
mor-initiating capacity in xenograft models (Visvader andhors
Lindeman, 2012), and have been shown to mediate metas-
tasis (Liu et al., 2010) and increased resistance against
radiotherapy and chemotherapy, contributing to relapse
following therapy (Li et al., 2008; Yu et al., 2007; Zhang
et al., 2010). The CSC concept has pivotal clinical implica-
tions for effective cancer treatments, since specific subpop-
ulations in a tumor need to be targeted and monitored in
order to better control tumor progression. However, diver-
sity of breast cancer phenotypes as well as cellular plasticity
complicate categorization of CSCs and, as a consequence,
effective targeting of critical subpopulations of cancer cells.
Breast cancer cell lines can be classified into luminal
(ERa+) and basal (ERa) subtypes based on transcriptomic
signatures (Charafe-Jauffret et al., 2006; Neve et al., 2006),
and further contain cells with increased tumorigenic po-
tential, i.e. CSCs (Charafe-Jauffret et al., 2009; Fillmore
and Kuperwasser, 2008). Similarities between cell lines
and primary breast cancer samples therefore support that
cell lines can be used as relevantmodel systems for defining
CSC properties and potential markers in cancer. The chal-
lenge is to define CSCs and other subpopulations and
determine their relation to each other. The enrichment
and detection of CSCs in breast cancer have relied on a
few phenotypic markers (Al-Hajj et al., 2003; Ginestier
et al., 2007), which has limited our understanding of cell
transitions between tumor cells with various degrees of
CSC characteristics.
To modulate stemness and differentiation, we therefore
applied three functional CSC enrichment techniques,mak-
ing use of inherent CSC properties, thereby circumventing
obstacles associated with phenotypical CSC selection. As
shown earlier (Harrison et al., 2010, 2013; Ponti et al.,
2005; Richichi et al., 2013) and presented in the results,
all our CSC enrichment techniques increased the number
of cells with stem cell properties, allowing us to detail
this rare subpopulation of cancer cells. For a comprehen-
sive analysis of CSC heterogeneity and tumor cell transi-
tions, we employed single-cell gene expression profiling,
assessing mRNA levels of well-established differentiation-,
breast cancer stem cell-, pluripotency-, EMT-, and prolifer-
ation-associated genes in CSC-enriched and corresponding
non-CSC populations. By applying single-cell gene expres-
sion profiling in different conditions with variable
numbers of CSCs and differentiated cells, we were able to
define cell states and determine their transition in relation
to stemness, EMT, proliferation, and differentiation in a
time-dependent manner using established approaches
(Rusnakova et al., 2013; Stahlberg et al., 2011; Trapnell
et al., 2014).
Comparison of two ERa+ cell lines (MCF7 and T47D)
identified virtually identical regulated transcripts and an
increase in common gene correlations in CSC-enriched
cells. Despite similarities in gene expression in subpopula-Stem Cetions, there were clear differences in subcellular transition
principles between cell lines. T47D cells transitioned
from a quiescent state to a more differentiated phenotype
in a switch-like fashion, i.e., no or few cells were present
in the PCA scores plot between cluster ERa+ I and III (Fig-
ure 4A), whereas MCF7 cells gradually differentiated via a
progenitor-like state to acquire a more differentiated
phenotype, i.e., cells were present throughout the PCA
scores plot between clusters I, II, and III (Figure 4A). Con-
version between differentiation states has earlier been
demonstrated in breast cancer cells (Chaffer et al., 2011;
Gupta et al., 2011); however, the studies were based on
the assessment of three markers (CD44, CD24, EPCAM)
to distinguish luminal, basal, and CSC-like lineages. Here,
assessing the expression of 21-80 transcripts per individual
cell, we present a much more detailed subpopulation anal-
ysis of breast cancer cells, indeed delineating progression
and transit between differentiation stages in breast cancer.
To scrutinize the relationship between different breast
cancer subtypes and the presence of CSC markers, we
compared single-cell gene expression signatures of ERa+
and ERa cell lines (CAL120 and MDA231). In contrast
to ERa+ cell lines, ERa cell lines produced a less well-
defined separation of regular cultured and CSC-enriched
cells, which could either be due to the fact that our applied
gene panel did not optimally separate CSC-enriched
populations or that ERa cell lines do not exhibit a strict
hierarchical organization in line with observations in mel-
anomas (Quintana et al., 2010). ERa cell lines are further
characterized by a basal/mesenchymal phenotype, which
may in part mask differentiation (Fillmore and Kuper-
wasser, 2008; Meyer et al., 2010). Our results nevertheless
suggest that ERa breast CSCs cluster based on prolifera-
tive capacity. This is also in line with the identification of
a common CSC pool between ERa+ and ERa cell lines
that was quiescent by nature, i.e., exhibited low overall
transcript levels, which has been described for cells residing
in a dormant state (Cheung and Rando, 2013; Fukada et al.,
2007; Huttmann et al., 2001) (Figure 4). Upon differentia-
tion, ERa+ and ERa cell lines activate partly different
pathways by regulating specific genes, which give rise to
the more mature cell types that characterize these breast
cancer subtypes (Figure 4). In line with our cell line data,
our proposed model of cell states and cell transition origi-
nating from a common CSC pool was supported by data
generated from primary tumors.
The multitude of analyses performed using MCF7 cells
allowed us to pool the various data and perform in-depth
single-cell analyses, which identified four distinct subpop-
ulations and differentiation states featuring clear-cut gene
expression signatures. The most immature subpopulation
displayed qualities of quiescent and pluripotent CSCs fol-
lowed by distinct progenitor-like states before acquiring all Reports j Vol. 6 j 121–136 j January 12, 2016 j ª2016 The Authors 133
more differentiated phenotype. Gradual up- and downre-
gulation of differentiation-, cell-cycle-, EMT-, and stem-
ness-related genes across the multiple cell states suggests
a strict hierarchical organization of MCF7 cells. Whether
cells transition through multiple cellular differentiation
states in a uni- or bidirectional manner has not explicitly
been addressed in this study, although several lines of evi-
dence have recently reported a high degree of cellular plas-
ticity and the capability of cells to switch betweenmultiple
cellular phenotypes (Chaffer et al., 2011; D’Amato et al.,
2012; Gupta et al., 2011; Liu et al., 2014; Su et al., 2015).
Furthermore, our single-cell analysis allowed us to deter-
mine the sequential order of events in CSC differentiation
at a transcriptional level, since we analyzed individual tu-
mor cells in different pre-defined conditions (Stahlberg
et al., 2011). First, differentiation-associated genes were
activated in immature CSCs at the same time as EMT and
breast cancer-associated stem cell markers were downregu-
lated. Second, we observed increased expression of prolifer-
ation markers and downregulation of genes related to
stemness. This progression sequence is further in line
with normal stem cell differentiation and development
(D’Amour et al., 2005; Norrman et al., 2012). Temporal
mapping of molecular mechanisms in differentiation and
cellular transition modes in fact allows the identification
of key events in CSC plasticity. For example, in an attempt
to target de-differentiation of progenitor cells into less-
differentiated cells with pluripotent features, in ERa+
breast cancers, genes associated with differentiation/EMT/
breast cancer stemness need to be modulated rather than
pluripotency/proliferation, since these processes follow a
sequential order. However, in ERa cells, proliferation
seems to be one of the key differentiation-associated
events. Targeting proliferation in both ERa+ and especially
ERa breast cancermay actually have an effect on differen-
tiation processes, potentially increasing CSC subpopula-
tions and tumor aggressiveness. Our data highlight the
absolute need for proper tumor characterization and in-
depth understanding of relevant common as well as
separate differentiation and de-differentiation processes
present in subtypes of breast cancer.
In this study we present unique data showing how breast
cancer cells advance through a hierarchically organized
structure rendering in balanced fractions of highly differen-
tiated subpopulationsof cells aswell as cancer stemandpro-
genitor cells. Focus was set on delineating the definition
and composition of subpopulations with stem cell proper-
ties using single-cell qPCR of large sets of key regulators,
and the results highlighted a highly orchestrated subpopu-
lation-based organization in predominantly ERa+ breast
cancer but also with common features between ERa+ and
ERa CSC populations. The results are in line with earlier
reports suggesting lowly proliferative properties and the134 Stem Cell Reports j Vol. 6 j 121–136 j January 12, 2016 j ª2016 The Autpresence of pluripotency genes in CSCs as well as increased
resistance to chemotherapy (Fillmore and Kuperwasser,
2008; Gao et al., 2010; Moore and Lyle, 2011; Pece et al.,
2010), but in detail highlight the precise composition and
existence of subpopulations with cancer-initiating proper-
ties. Data from primary breast cancer cells also support the
cellular organization described in cell lines, and future
studies including additional genes or next-generation
sequencing data of larger sets of primary tumors can poten-
tially reveal further subdivision and classifications of the
now defined general principles of CSC pools in breast
cancer. Properties andhierarchicalmovementbetween can-
cer subpopulations will be important knowledge when
defining novel treatment approaches truly targeting CSCs
and key differentiation pathways revitalizing cancer stem
cell subpopulations during tumor progression.EXPERIMENTAL PROCEDURES
Extended experimental procedures are provided in the Supple-
mental Information.
CSC Enrichment Methods
To enrich for AR cells, single-cell suspensions were seeded in 1.2%
poly(2-hydroxyethyl methacrylate)/95% ethanol-coated plates
(Sigma-Aldrich) at a density of 500 cells cm2 and grown for
16 hr in phenol red-free DMEM/F-12 (Life Technologies) contain-
ing 2% B27 supplement (Life Technologies), 20 ngml1 epidermal
growth factor (BD Biosciences), and 1% penicillin/streptomycin
(PAA) as previously described (Harrison et al., 2010). For hypoxic
treatment cells were grown in the SCI-tiveN hypoxic workstation
(Ruskinn Technology) in 1% O2, 5% CO2, and 94% N2 in a
humidified environment at 37C for 48 hr. For PKH26 staining of
mammospheres, adherent cells were dissociated with 0.05%
trypsin-EDTA (PAA), washed with serum-free growth medium,
suspended in 1 ml of Diluent C for general membrane labeling
(Sigma-Aldrich), and syringed once with a 25-gauge needle. For
FACS, 2.5 3 106 cells ml1 were labeled with 1 mM PKH26 dye
(Sigma-Aldrich) for 3 min according to the manufacturer’s proto-
col. PKH26-labeled single cells were seeded at a cell density of
500 cells cm2 and grown in mammosphere culture for 5 days as
described for growth in anchorage-independent conditions. We
regularly observe viable PKH26Bright single cells in our mammo-
sphere cultures. To separate these PKH26Bright single cells from
mammosphere-derived PKH26Bright cells, sphere cultures were
centrifuged at 103 g for 3min, and supernatant (containing single
cells) andpellet (containingmammospheres)were collected.Mam-
mospheres were spun again at 1153 g for 5min and enzymatically
(0.05% trypsin-EDTA) andmanually (25-gauge needle) dissociated,
and washed twice with cold 13 PBS (pH 7.4) (Sigma-Aldrich) for
downstream cell collection by FACS or microaspiration.
Single-Cell Gene Expression Analysis
The reader is referred to the Supplemental Experimental Proce-
dures for a detailed description of applied methods used forhors
single-cell gene expression profiling. In short, individual cells were
collected by FACS or with a micromanipulator and subjected to
direct cell lysis, and immediately frozen on dry ice. RNA was
reverse transcribed followed by targeted cDNA pre-amplification
using gene-specific oligonucleotides and quantitative real-time
PCR to assess gene expression levels of selected genes.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and six tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2015.12.006.
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